Neural Correlates of Formal Thought Disorder Dimensions in Psychosis
Overview
Authors
Affiliations
Background And Hypothesis: Formal thought disorder (FTD) is a core symptom of psychosis, but its neural correlates remain poorly understood. This study tested whether four FTD dimensions differ in their association with brain perfusion and brain structure.
Study Design: This cross-sectional study investigated 110 patients with schizophrenia spectrum disorders using 3T magnetic resonance imaging (MRI). The Thought and Language Disorder scale (TALD) was utilized, which comprises four subscales: Objective Positive (OP), Objective Negative (ON), Subjective Positive (SP), and Subjective Negative (SN). Resting-state cerebral blood flow (rsCBF), cortical thickness (CortTh), gray matter volume (GMV), and diffusion MRI tractography were tested for associations with TALD subscales controlling for age, medication, total intracranial volume, and for variance of the 3 other TALD subscales.
Study Results: Following Bonferroni correction, the FTD dimensions presented distinct neural correlates. OP scores were associated with increased rsCBF and increased GMV in the right cerebellum lingual gyrus. Higher SP scores were linked to increased GMV in bilateral prefrontal cortex. In contrast, ON was associated with increased GMV in the right premotor cortex. At more liberal statistical thresholds, higher SP was associated with increased CortTh in the right inferior frontal gyrus, whereas SN scores were linked to decreased GMV in the right prefrontal lobe, the left inferior temporal gyrus, and the left supplementary motor area. Unadjusted analyses mostly corroborated these findings.
Conclusion: These findings stress the heterogeneity in FTD, suggesting distinct neural patterns for specific FTD experiences. In sum, FTD in psychosis may require distinct treatment strategies and further mechanistic investigations on single-item levels.
Alarabi M, Burton L, Powell V, Isinger T, Agarwal S, Remington G Can J Psychiatry. 2024; 70(3):229-239.
PMID: 39497431 PMC: 11562935. DOI: 10.1177/07067437241293985.
Boisvert M, Dugre J, Potvin S Psychol Med. 2024; :1-12.
PMID: 39397677 PMC: 11536122. DOI: 10.1017/S003329172400165X.
New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment.
Faris P, Pischedda D, Palesi F, DAngelo E Front Cell Neurosci. 2024; 18:1386583.
PMID: 38799988 PMC: 11116653. DOI: 10.3389/fncel.2024.1386583.
Sharkey R, Bacon C, Peterson Z, Rootes-Murdy K, Salvador R, Pomarol-Clotet E Mol Psychiatry. 2024; 29(10):3086-3096.
PMID: 38671214 PMC: 11449795. DOI: 10.1038/s41380-024-02563-z.
Lefebvre S, Gehrig G, Nadesalingam N, Nuoffer M, Kyrou A, Wuthrich F Brain. 2024; 147(4):1423-1435.
PMID: 38537253 PMC: 10994557. DOI: 10.1093/brain/awad395.